Genital Herpes Treatment Market
Market Insights on Genital Herpes Treatment covering sales outlook, demand forecast & up-to-date key trends
Genital Herpes Treatment Market by Drug Type (Acyclovir, Valacyclovir, Famciclovir), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores), Route of Administration, Indication & Region - Forecast to 2021-2031
Genital Herpes Treatment Market Snapshot
[279 Pages Report] Future Market Insights (FMI) in its latest market analysis forecasts that genital herpes treatment sales will accelerate at 1.5x in next ten years reaching the market valuation of US$ 2881.8 Mn by the end of 2031.
North America Genital Herpes Treatment Market will hold around 34.3% of global market share by 2021 owing to rising prevalence of genital herpes in U.S. and increasing healthcare spending in the region, as per FMI’s finding.
Growth predictions remain positive for Europe due to rising awareness regarding sexually transmissible infections and presence of leading market players in the U.K. and Germany. Spurred by this, the Europe genital herpes treatment market is projected to grow at about 3.4% CAGR during the forecast period.
Customize this Report
Let us know your requirement to get
100% FREE customization
Key Points Covered in Genital Herpes Treatment Market Study
- Genital Herpes Treatment Market estimates and forecast 2021 – 2031
- Key drivers and restrains impacting market growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competitive Mapping and Benchmarking
- Brand share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact On Genital Herpes Treatment Market and How to Navigate
- Recommendation on Key Winning Strategies
2016 – 2020 Genital Herpes Treatment Market Outlook In Comparison to 2021 – 2031 Forecasts
Genital herpes cases are on the rise in western hemisphere especially in U.S., U.K. and Germany. The Center of Disease Control and Prevention states that one out of every six people in U.S. between the ages of 14 to 49 years is affected with genital herpes.
Increase in demand for genital herpes treatment will create prospects for expansion of the market. FMI reports that the genital herpes treatment market showcased a modest growth of 4% CAGR in past five years.
Rising cases of genital herpes in countries in Asia such as China and India will rev up growth opportunities for the market. The growth trend will continue in response to increasing healthcare spending registered in emerging economies.
Vaccine development for genital herpes is on the cards as pharmaceutical market leaders are focusing on new drug development and are also collaborating with research institutes for clinical trials and faster product development.
For instance, Sanofi Pasteur in collaboration with National Institute of Allergy and Infectious Diseases is currently developing a herpes vaccine called HSV529 (HSV15). The vaccine is classified as a replication-defective virus which means the virus possesses all the HSV virus components except two proteins important UL5 and UL29, involved in viral DNA replication.
In March 2021, GlaxoSmithKline plc began its phase 1 human clinical trials for its experimental HSV-2 vaccine to study the reactogenicity, safety, and immunogenicity of four different dose levels of the vaccine in healthy participants aged 18-40 years.
Rapid advancement in the field of virology and increasing investment towards modern medicine and therapeutic treatment development will boost the genital herpes treatment market growth globally throughout upcoming decade.
Famciclovir to emerge as another lucrative drug type after a long rule by Acyclovir
The genital herpes treatment includes the use of drug types like Acyclovir that can treat herpes virus infections, including shingles. This medication does not cure herpes, but may prevent herpes sores or blisters.
It is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Zovirax is the main brand available in the market for genital herpes. It can also treat chickenpox.
The other one is Valacyclovir which is used to treat infections caused by certain types of viruses. In children, it is used to treat cold sores around the mouth (caused by herpes simplex) and chickenpox (caused by varicella zoster).
In adults, it is used to treat shingles (caused by herpes zoster) and cold sores around the mouth. It is an influenza antiviral drug. It stops the growth of certain viruses. However, it is not a cure for these infections. Famciclovir is an antiviral drug. However, it is not a cure for these infections.
The viruses that cause these infections continue to live in the body even between outbreaks. Famvir is typically used as a one-time treatment that stops the spread or prevents the symptoms from becoming a hassle.
It treats shingles caused by herpes zoster. It also treats outbreaks of herpes simplex that cause cold sores around the mouth, sores around the anus, and genital herpes.
Among these drug types prevalent in the genital herpes treatment, Acyclovir segment dominated the global genital herpes treatment market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period.
However, Famciclovir is a drug type that is expected to gain popularity in the forecast period, and grow at a high CAGR of 5.0% during the forecast period.
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystIncreasing demand for genital herpes treatment drugs by homosexuals to be observed in the coming years
The detailed analysis of genital herpes treatment market has helped the researchers to get crucial insights. It includes results like more prevalence of HSV-2 in homosexuals. Chances of genital herpes are more in the male same-sex partnership compared to female same-sex partnership. Homosexual men are known to be at high risk for herpes simplex virus (HSV), which can be transmitted by direct intimate contact with a person who is shedding virus, and not only through ano-genital sex.
Herpes virus type 2 (HSV2) is generally considered as a useful marker for sexual behavior in a population 50% of the homosexual population in Latin America has the risk of sexually transmitted diseases such as HSV-2 genital herpes and HIV, which would increase the demand for genital herpes treatment and drive the market.
A new trend depicts increasing clinical trial of vaccines for genital herpes
Companies are increasing the clinical trials for genital herpes vaccine for advance prevention & treatment of genital herpes. Geneva is developing vaccines for genital herpes and doing clinical trial of GEN-003. It is potentially the first-ever therapeutic vaccine for a chronic infection and first advancement in the treatment of genital herpes in more than 20 years. GEN-003 is a Phase 3-ready investigational immunotherapy for the treatment of genital herpes infections. These new developments will increase the growth of the genital herpes treatment market especially in Western Europe.
Become a MarketNgage Insider
A unified Market Research Subscription Platform, built for today's disparate research needs.
Global Genital Herpes Treatment Market: Top Companies
Some of the leading companies mentioned in the research report are Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Sun Pharmaceuticals Industries Ltd., Mylan N.V., Pfizer Inc., GlaxoSmithKline plc, Dr. Reddy’s Laboratories, ltd., Novartis AG, Valeant Pharmaceuticals International Inc. etc.
This list is indicative - full details about prominent genital herpes treatment manufacturers is available upon request
Genital herpes Treatment Market – Report Scope
|
Attribute |
Details |
|
Genital Herpes Treatment Market Forecast Period |
2021 – 2031 |
|
Historical Data Available for |
2017 – 2027 |
|
Genital Herpes Treatment Market Analysis |
US$ Mn for Value & Units for Volume |
|
Key Regions Covered |
North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East and Africa |
|
Key Countries Covered |
U.S., Canada, Brazil, Mexico, Argentina, Rest of Latin America, EU-5, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Denmark, Finland, Iceland, Norway, Sweden), Rest of Western Europe, Poland, Russia, Rest of Eastern Europe, China, India, Japan, GCC Countries, South Africa, Israel, Turkey, Iran, Rest of Middle East & Africa, Australia, New Zealand, South Korea, the Philippines, Malaysia, and Thailand |
|
Genital Herpes Treatment Market - Key Segments Covered |
Drug type, Distribution Channel, Route of Administration, Indication and Region |
|
Key Companies Profiled |
|
|
Genital Herpes Treatment Market - Report Coverage |
Market Overview, Market Background, Market Forecast, Segmental Analysis, Regional Profiling and Competition Analysis |
|
Customization & Pricing |
Available upon Request |
Key Segments Covered in Genital herpes treatment Market Study
Drug Type:
- Acyclovir
- Valacyclovir
- Famciclovir
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
Route of Administration:
- Oral
- Topical
- Injectable
Indication:
- HSV-1
- HSV-2
Key Regions/Countries Covered:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific Ex. Japan (APEJ)
- Japan
- Middle East & Africa
Frequently Asked Questions
How much is the genital herpes treatment market worth?
Driven by increasing prevalence of genital herpes in younger population across the globe, the genital herpes treatment market is forecast to grow at 4.76% from 2021, reaching the valuation of US$ 1947.2 Mn in 2021.
At what rate did the genital herpes treatment market expand in the last five years?
Between 2016 and 2020, the genital herpes treatment market grew at a 4.0% CAGR.
What will be the demand outlook/ sales forecast of genital herpes treatment?
The global genital herpes treatment sale is forecast to exceed the valuation of US$ 2881.8 Mn by the end of 2031.
Which countries are key producers of genital herpes treatment?
Leading countries driving the production of the genital herpes treatment are U.S., China, and India.
What is the North America genital herpes treatment market outlook?
Demand registered in North America will continue rising, backed increasing sales in the U.S. and Canada, the North America will engulf around 34.2% of global market share by 2031.
Who are the leading five companies in genital herpes treatment market?
Novartis AG, Pfizer Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd and Abbott Laboratories are the top five companies operating in the market.
What is the cumulative share of top companies in genital herpes treatment market?
Top five market players account for around 54.5% of the global genital herpes treatment market share.
At what rate will genital herpes treatment sales increase in Europe?
Genital herpes treatment sales will increase at 3.4% CAGR in Europe, backed by rising demand in the U.K., Germany, and other countries.
Which are the top five countries driving genital herpes treatment market demand?
Leading countries driving demand in the genital herpes treatment market are U.S., China, India Germany, and U.K.
What are the key statistics for genital herpes treatment market in China and Japan?
Japan and China held 7.1% and 3.6% share, respectively in the overall genital herpes treatment market in 2021.
Table of Content
1. Executive Summary 1.1. Market Overview 1.2. Market Analysis 1.3. FMI Analysis and Recommendations 1.4. Wheel of Fortune 2. Market Introduction 2.1. Market Taxonomy 2.2. Market Definition 3. Genital Herpes Treatment Market View Point 3.1. Macro-Economic Factors 3.2. Opportunity Analysis 4. North America Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027 4.1. Introduction 4.2. Regional Market Dynamics 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Trends 4.3. Historical Market Size (US$ Mn) By Country, 2012-2016 4.3.1. U.S. 4.3.2. Canada 4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027 4.4.1. U.S. 4.4.2. Canada 4.5. Historical Market Size (US$ Mn) By Drug Type 2012-2016 4.5.1. Acyclovir 4.5.2. Valacyclovir 4.5.3. Famciclovir 4.6. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027 4.6.1. Acyclovir 4.6.2. Valacyclovir 4.6.3. Famciclovir 4.7. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016 4.7.1. Oral 4.7.2. Topical 4.7.3. Injectable 4.8. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027 4.8.1. Oral 4.8.2. Topical 4.8.3. Injectable 4.9. Historical Market Size (US$ Mn) By Indication, 2012-2016 4.9.1. HSV-1 4.9.2. HSV-2 4.10. Market Size (US$ Mn) Forecast By Indication, 2017-2027 4.10.1. HSV-1 4.10.2. HSV-2 4.11. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016 4.11.1. Hospital Pharmacies 4.11.2. Retail Pharmacies 4.11.3. Online Pharmacies 4.11.4. Drug Stores 4.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027 4.12.1. Hospital Pharmacies 4.12.2. Retail Pharmacies 4.12.3. Online Pharmacies 4.12.4. Drug Stores 4.13. Drivers and Restraints: Impact Analysis 4.14. Market Attractiveness Analysis 4.14.1. By Country 4.14.2. By Drug Type 4.14.3. By Route of Administration 4.14.4. By Indication 4.14.5. By Distribution Channel 4.15. Key Representative Market Participants 4.16. Key Participants Market Presence (Intensity Map) 5. Western Europe Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027 5.1. Introduction 5.2. Regional Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Trends 5.3. Historical Market Size (US$ Mn) By Country, 2012-2016 5.3.1. Germany 5.3.2. U.K 5.3.3. France 5.3.4. Italy 5.3.5. Spain 5.3.6. Rest of Western Europe 5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027 5.4.1. Germany 5.4.2. U.K 5.4.3. France 5.4.4. Italy 5.4.5. Spain 5.4.6. Rest of Western Europe 5.5. Historical Market Size (US$ Mn) By Drug Type 2012-2016 5.5.1. Acyclovir 5.5.2. Valacyclovir 5.5.3. Famciclovir 5.6. Historical Market Size (US$ Mn) By Drug Type 2012-2016 5.6.1. Acyclovir 5.6.2. Valacyclovir 5.6.3. Famciclovir 5.7. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027 5.7.1. Acyclovir 5.7.2. Valacyclovir 5.7.3. Famciclovir 5.8. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016 5.8.1. Oral 5.8.2. Topical 5.8.3. Injectable 5.9. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027 5.9.1. Oral 5.9.2. Topical 5.9.3. Injectable 5.10. Historical Market Size (US$ Mn) By Indication, 2012-2016 5.10.1. HSV-1 5.10.2. HSV-2 5.11. Market Size (US$ Mn) Forecast By Indication, 2017-2027 5.11.1. HSV-1 5.11.2. HSV-2 5.12. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016 5.12.1. Hospital Pharmacies 5.12.2. Retail Pharmacies 5.12.3. Online Pharmacies 5.12.4. Drug Stores 5.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027 5.13.1. Hospital Pharmacies 5.13.2. Retail Pharmacies 5.13.3. Online Pharmacies 5.13.4. Drug Stores 5.14. Drivers and Restraints: Impact Analysis 5.15. Market Attractiveness Analysis 5.15.1. By Country 5.15.2. By Drug Type 5.15.3. By Route of Administration 5.15.4. By Indication 5.15.5. By Distribution Channel 5.16. Key Representative Market Participants 5.17. Key Participants Market Presence (Intensity Map) 6. Eastern Europe Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027 6.1. Introduction 6.2. Regional Market Dynamics 6.2.1. Drivers 6.2.2. Restraints 6.2.3. Trends 6.3. Historical Market Size (US$ Mn) By Country, 2012-2016 6.3.1. Russia 6.3.2. Poland 6.3.3. Rest of Eastern Europe 6.4. Market Size (US$ Mn) Forecast By Country, 2017-2027 6.4.1. Russia 6.4.2. Poland 6.4.3. Rest of Eastern Europe 6.5. Historical Market Size (US$ Mn) By Drug Type 2012-2016 6.5.1. Acyclovir 6.5.2. Valacyclovir 6.5.3. Famciclovir 6.6. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027 6.6.1. Acyclovir 6.6.2. Valacyclovir 6.6.3. Famciclovir 6.7. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016 6.7.1. Oral 6.7.2. Topical 6.7.3. Injectable 6.8. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027 6.8.1. Oral 6.8.2. Topical 6.8.3. Injectable 6.9. Historical Market Size (US$ Mn) By Indication, 2012-2016 6.9.1. HSV-1 6.9.2. HSV-2 6.10. Market Size (US$ Mn) Forecast By Indication, 2017-2027 6.10.1. HSV-1 6.10.2. HSV-2 6.11. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016 6.11.1. Hospital Pharmacies 6.11.2. Retail Pharmacies 6.11.3. Online Pharmacies 6.11.4. Drug Stores 6.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027 6.12.1. Hospital Pharmacies 6.12.2. Retail Pharmacies 6.12.3. Online Pharmacies 6.12.4. Drug Stores 6.13. Drivers and Restraints: Impact Analysis 6.14. Market Attractiveness Analysis 6.14.1. By Country 6.14.2. By Drug Type 6.14.3. By Route of Administration 6.14.4. By Indication 6.14.5. By Distribution Channel 6.15. Key Representative Market Participants 6.16. Key Participants Market Presence (Intensity Map) 7. Latin America Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027 7.1. Introduction 7.2. Regional Market Dynamics 7.2.1. Drivers 7.2.2. Restraints 7.2.3. Trends 7.3. Historical Market Size (US$ Mn) By Country, 2012-2016 7.3.1. Brazil 7.3.2. Mexico 7.3.3. Rest of Latin America 7.4. Market Size (US$ Mn) Forecast By Country, 2017-2027 7.4.1. Brazil 7.4.2. Mexico 7.4.3. Rest of Latin America 7.5. Historical Market Size (US$ Mn) By Drug Type 2012-2016 7.5.1. Acyclovir 7.5.2. Valacyclovir 7.5.3. Famciclovir 7.6. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027 7.6.1. Acyclovir 7.6.2. Valacyclovir 7.6.3. Famciclovir 7.7. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016 7.7.1. Oral 7.7.2. Topical 7.7.3. Injectable 7.8. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027 7.8.1. Oral 7.8.2. Topical 7.8.3. Injectable 7.9. Historical Market Size (US$ Mn) By Indication, 2012-2016 7.9.1. HSV-1 7.9.2. HSV-2 7.10. Market Size (US$ Mn) Forecast By Indication, 2017-2027 7.10.1. HSV-1 7.10.2. HSV-2 7.11. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016 7.11.1. Hospital Pharmacies 7.11.2. Retail Pharmacies 7.11.3. Online Pharmacies 7.11.4. Drug Stores 7.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027 7.12.1. Hospital Pharmacies 7.12.2. Retail Pharmacies 7.12.3. Online Pharmacies 7.12.4. Drug Stores 7.13. Drivers and Restraints: Impact Analysis 7.14. Market Attractiveness Analysis 7.14.1. By Country 7.14.2. By Drug Type 7.14.3. By Route of Administration 7.14.4. By Indication 7.14.5. By Distribution Channel 7.15. Key Representative Market Participants 7.16. Key Participants Market Presence (Intensity Map) 8. Asia Pacific Excluding Japan Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027 8.1. Introduction 8.2. Regional Market Dynamics 8.2.1. Drivers 8.2.2. Restraints 8.2.3. Trends 8.3. Historical Market Size (US$ Mn) By Country, 2012-2016 8.3.1. China 8.3.2. India 8.3.3. Australia and New Zealand 8.3.4. ASEAN 8.3.5. Rest of APEJ 8.4. Market Size (US$ Mn) Forecast By Country, 2017-2027 8.4.1. China 8.4.2. India 8.4.3. Australia and New Zealand 8.4.4. ASEAN 8.4.5. Rest of APEJ 8.5. Historical Market Size (US$ Mn) By Drug Type 2012-2016 8.5.1. Acyclovir 8.5.2. Valacyclovir 8.5.3. Famciclovir 8.6. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027 8.6.1. Acyclovir 8.6.2. Valacyclovir 8.6.3. Famciclovir 8.7. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016 8.7.1. Oral 8.7.2. Topical 8.7.3. Injectable 8.8. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027 8.8.1. Oral 8.8.2. Topical 8.8.3. Injectable 8.9. Historical Market Size (US$ Mn) By Indication, 2012-2016 8.9.1. HSV-1 8.9.2. HSV-2 8.10. Market Size (US$ Mn) Forecast By Indication, 2017-2027 8.10.1. HSV-1 8.10.2. HSV-2 8.11. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016 8.11.1. Hospital Pharmacies 8.11.2. Retail Pharmacies 8.11.3. Online Pharmacies 8.11.4. Drug Stores 8.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027 8.12.1. Hospital Pharmacies 8.12.2. Retail Pharmacies 8.12.3. Online Pharmacies 8.12.4. Drug Stores 8.13. Drivers and Restraints: Impact Analysis 8.14. Market Attractiveness Analysis 8.14.1. By Country 8.14.2. By Drug Type 8.14.3. By Route of Administration 8.14.4. By Indication 8.14.5. By Distribution Channel 8.15. Key Representative Market Participants 8.16. Key Participants Market Presence (Intensity Map) 9. Japan Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027 9.1. Introduction 9.2. Regional Market Dynamics 9.2.1. Drivers 9.2.2. Restraints 9.2.3. Trends 9.3. Historical Market Size (US$ Mn) By Drug Type 2012-2016 9.3.1. Acyclovir 9.3.2. Valacyclovir 9.3.3. Famciclovir 9.4. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027 9.4.1. Acyclovir 9.4.2. Valacyclovir 9.4.3. Famciclovir 9.5. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016 9.5.1. Oral 9.5.2. Topical 9.5.3. Injectable 9.6. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027 9.6.1. Oral 9.6.2. Topical 9.6.3. Injectable 9.7. Historical Market Size (US$ Mn) By Indication, 2012-2016 9.7.1. HSV-1 9.7.2. HSV-2 9.8. Market Size (US$ Mn) Forecast By Indication, 2017-2027 9.8.1. HSV-1 9.8.2. HSV-2 9.9. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016 9.9.1. Hospital Pharmacies 9.9.2. Retail Pharmacies 9.9.3. Online Pharmacies 9.9.4. Drug Stores 9.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027 9.10.1. Hospital Pharmacies 9.10.2. Retail Pharmacies 9.10.3. Online Pharmacies 9.10.4. Drug Stores 9.11. Drivers and Restraints: Impact Analysis 9.12. Market Attractiveness Analysis 9.12.1. By Country 9.12.2. By Drug Type 9.12.3. By Route of Administration 9.12.4. By Indication 9.12.5. By Distribution Channel 9.13. Key Representative Market Participants 9.14. Key Participants Market Presence (Intensity Map) 10. Middle East and Africa Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027 10.1. Introduction 10.2. Regional Market Dynamics 10.2.1. Drivers 10.2.2. Restraints 10.2.3. Trends 10.3. Historical Market Size (US$ Mn) By Country, 2012-2016 10.3.1. GCC Countries 10.3.2. South Africa 10.3.3. North Africa 10.3.4. Rest of Middle East and Africa 10.4. Market Size (US$ Mn) Forecast By Country, 2017-2027 10.4.1. GCC Countries 10.4.2. South Africa 10.4.3. Rest of Middle East and Africa 10.5. Historical Market Size (US$ Mn) By Drug Type 2012-2016 10.5.1. Acyclovir 10.5.2. Valacyclovir 10.5.3. Famciclovir 10.6. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027 10.6.1. Acyclovir 10.6.2. Valacyclovir 10.6.3. Famciclovir 10.7. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016 10.7.1. Oral 10.7.2. Topical 10.7.3. Injectable 10.8. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027 10.8.1. Oral 10.8.2. Topical 10.8.3. Injectable 10.9. Historical Market Size (US$ Mn) By Indication, 2012-2016 10.9.1. HSV-1 10.9.2. HSV-2 10.10. Market Size (US$ Mn) Forecast By Indication, 2017-2027 10.10.1. HSV-1 10.10.2. HSV-2 10.11. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016 10.11.1. Hospital Pharmacies 10.11.2. Retail Pharmacies 10.11.3. Online Pharmacies 10.11.4. Drug Stores 10.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027 10.12.1. Hospital Pharmacies 10.12.2. Retail Pharmacies 10.12.3. Online Pharmacies 10.12.4. Drug Stores 10.13. Drivers and Restraints: Impact Analysis 10.14. Market Attractiveness Analysis 10.14.1. By Country 10.14.2. By Drug Type 10.14.3. By Route of Administration 10.14.4. By Indication 10.14.5. By Distribution Channel 10.15. Key Representative Market Participants 10.16. Key Participants Market Presence (Intensity Map) 11. Forecast Factors: Relevance and Impact 12. Forecast Assumptions 13. Competition Landscape 13.1. Market Structure 13.2. Market Share Analysis (2016) 13.3. Competition Intensity Mapping By Market Taxonomy 13.4. Competition Dashboard 13.5. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments) 13.5.1. Teva Pharmaceutical Industries Ltd. 13.5.2. Abbott Laboratories 13.5.3. Sun Pharmaceuticals Industries Ltd. 13.5.4. Mylan N.V. 13.5.5. Pfizer Inc. 13.5.6. GlaxoSmithKline plc. 13.5.7. Dr. Reddy’s Laboratories, ltd. 13.5.8. Novartis AG 13.5.9. Valeant Pharmaceuticals International Inc. 14. Global Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027 By Region 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) By Region, 2012-2016 14.2.1. North America 14.2.2. Western Europe 14.2.3. Eastern Europe 14.2.4. Latin America 14.2.5. Asia Pacific Excluding Japan 14.2.6. Japan 14.2.7. Middle East and Africa 14.3. Market Size (US$ Mn) Forecast By Region, 2017-2027 14.3.1. North America 14.3.2. Western Europe 14.3.3. Eastern Europe 14.3.4. Latin America 14.3.5. Asia Pacific Excluding Japan 14.3.6. Japan 14.3.7. Middle East and Africa 14.4. Market Attractiveness Analysis By Region 15. Global Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Drug Type 15.1. Introduction/Key Finding 15.2. Historical Market Size (US$ Mn) By Drug Type 2012-2016 15.2.1. Acyclovir 15.2.2. Valacyclovir 15.2.3. Famciclovir 15.3. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027 15.3.1. Acyclovir 15.3.2. Valacyclovir 15.3.3. Famciclovir 15.4. Market Attractiveness Analysis By Drug Type 16. Global Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Route of Administration 16.1. Introduction/Key Finding 16.2. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016 16.2.1. Oral 16.2.2. Topical 16.2.3. Injectable 16.3. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027 16.3.1. Oral 16.3.2. Topical 16.3.3. Injectable 16.4. Market Attractiveness Analysis By Route of Administration 17. Global Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Indication 17.1. Introduction/Key Finding 17.2. Historical Market Size (US$ Mn) By Indication, 2012-2016 17.2.1. HSV-1 17.2.2. HSV-2 17.3. Market Size (US$ Mn) Forecast By Indication, 2017-2027 17.3.1. HSV-1 17.3.2. HSV-2 17.4. Market Attractiveness Analysis By Indication 18. Global Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Distribution Channel 18.1. Introduction/Key Finding 18.2. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016 18.2.1. Hospital Pharmacies 18.2.2. Retail Pharmacies 18.2.3. Online Pharmacies 18.2.4. Drug Stores 18.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027 18.3.1. Hospital Pharmacies 18.3.2. Retail Pharmacies 18.3.3. Online Pharmacies 18.3.4. Drug Stores 18.4. Market Attractiveness Analysis By Distribution Channel 19. Global Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027 19.1. Market Size and Y-o-Y Growth 19.2. Absolute $ Opportunity 20. Assumptions and Acronyms Used 21. Research Methodology
Customize this Report
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: North America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country Table 02: North America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type Table 03: North America Genital Herpes Treatment Market size (US$ Mn)Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration Table 04: North America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication Table 05: North America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel Table 06: North America Genital Herpes Treatment Market Participants Presence (Intensity Mapping) Table 07: Latin America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country Table 08: Latin America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type Table 09: Latin America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration Table 10: Latin America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication Table 11: Latin America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel Table 12: Latin America Genital Herpes Treatment Market Participants Presence (Intensity Mapping) Table 13: Western Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country Table 14: Western Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type Table 15: Western Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration Table 16: Western Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication Table 17: Western Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel Table 18: Western Europe Genital Herpes Treatment Market Participants Presence (Intensity Mapping) Table 19: Eastern Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country Table 20: Eastern Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type Table 21: Eastern Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration Table 22: Eastern Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication Table 23: Eastern Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel Table 24: Eastern Europe Genital Herpes Treatment Market Participants Presence (Intensity Mapping) Table 25: APEJ Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country Table 26: APEJ Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type Table 27: APEJ Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration Table 28: APEJ Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication Table 29: APEJ Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel Table 30: APEJ Genital Herpes Treatment Market Participants Presence (Intensity Mapping) Table 31: Japan Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type Table 32: Japan Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration Table 33: Japan Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication Table 34: Japan Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel Table 35: Japan Genital Herpes Treatment Market Participants Presence (Intensity Mapping) Table 36: MEA Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country Table 37: MEA Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type Table 38: MEA Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration Table 39: MEA Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication Table 40: MEA Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel Table 41: MEA Genital Herpes Treatment Market Participants Presence (Intensity Mapping) Table 42: Global Genital Herpes Treatment Market Size (US$ Mn) Forecast By Region, 2012–2017 Table 43: Global Genital Herpes Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Drug Type Table 44: Global Genital Herpes Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Route of Administration Table 45: Global Genital Herpes Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Indication Table 46: Global Genital Herpes Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Distribution Channel
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Genital Herpes Treatment Market Value Share By Drug Type 2016 (A) Figure 02: Global Genital Herpes Treatment Market Value Share By Route of Administration 2016 (A) Figure 03: Global Genital Herpes Treatment Market Value Share By Indication 2016 (A) Figure 04: Global Genital Herpes Treatment Market Value Share By Distribution Channel 2016 (A) Figure 05: Genital Herpes Treatment Market Split By Drug Type (2017) Figure 06: Genital Herpes Treatment Market Split By Route of Administration(2017) Figure 07: Genital Herpes Treatment Market Split By Indication(2017) Figure 08: Genital Herpes Treatment Market Split By Distribution Channel (2017) Figure 09: Genital Herpes Treatment Market Split By Country (2017) Figure 10: North America Genital Herpes Treatment Market Size Analysis, 2012–2016 Figure 11: North America Genital Herpes Treatment Market Forecast & Y-o-Y growth, 2017–2027 Figure 12: U.S. Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 13: U.S. Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 14: Canada Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 15: Canada Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 16: Acyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 17: Acyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 18: Valacyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 19: Valacyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 20: Famciclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 21: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 22: Oral Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 23: Oral Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 24: Topical Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 25: Topical Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 26: Injectable Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 27: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 28: HSV-1 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 29: HSV-1 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 30: HSV-2 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 31: HSV-2 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 32: Hospital Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 33: Hospital Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 34: Retail Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 35: Retail Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 36: Online Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 37: Online Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 38: Drug Stores Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 39: Drug Stores Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 40: North America Genital Herpes Treatment Market Attractiveness Analysis By Drug Class, 2017–2027 Figure 41: North America Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 Figure 42: North America Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 Figure 43: North America Genital Herpes Treatment Market Attractiveness Analysis By Distributor Channel, 2017–2027 Figure 44: North America Genital Herpes Treatment Market Attractiveness Analysis By Country, 2017–2027 Figure 45: Genital Herpes Treatment Market Split By Drug Type (2017) Figure 46: Genital Herpes Treatment Market Split By Route of Administration(2017) Figure 47: Genital Herpes Treatment Market Split By Indication(2017) Figure 48: Genital Herpes Treatment Market Split By Distribution Channel (2017) Figure 49: Genital Herpes Treatment Market Split By Country (2017) Figure 50: Latin America Genital Herpes Treatment Market Size Analysis, 2012–2016 Figure 51: Latin America Genital Herpes Treatment Market Forecast & Y-o-Y growth, 2017–2027 Figure 52: Brazil Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 53: Brazil Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 54: Mexico Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 55: Mexico Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 56: Rest of Latin America Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2017 Figure 57: Rest of Latin America Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 58: Acyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 59: Acyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 60: Valacyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 61: Valacyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 62: Famciclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 63: Famciclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 64: Oral Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 65: Oral Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 66: Topical Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 67: Topical Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 68: Injectable Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 69: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 70: HSV-1 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 71: HSV-1 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 72: HSV-2 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 73: HSV-2 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 74: Hospital Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 75: Hospital Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 76: Retail Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 77: Retail Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 78: Online Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 79: Online Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 80: Drug Stores Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 81: Drug Stores Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 82: Latin America Genital Herpes Treatment Market Attractiveness Analysis By Drug Class, 2017–2027 Figure 83: Latin America Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 Figure 84: Latin America Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 Figure 85: Latin America Genital Herpes Treatment Market Attractiveness Analysis By Distributor Channel, 2017–2027 Figure 86: Latin America Genital Herpes Treatment Market Attractiveness Analysis By Country, 2017–2027 Figure 87: Genital Herpes Treatment Market Split By Drug Type (2017) Figure 88: Genital Herpes Treatment Market Split By Route of Administration(2017) Figure 89: Genital Herpes Treatment Market Split By Indication(2017) Figure 90: Genital Herpes Treatment Market Split By Distribution Channel (2017) Figure 91: Genital Herpes Treatment Market Split By Country (2017) Figure 92: Western Europe Genital Herpes Treatment Market Size Analysis, 2012–2016 Figure 93: Western Europe Genital Herpes Treatment Market Forecast & Y-o-Y growth, 2017–2027 Figure 94: Germany Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 95: Germany Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 96: U.K. Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 97: U.K. Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 98: France Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 99: France Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 100: Italy Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 101: Italy Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 102: Spain Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 103: Spain Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 104: Rest of Western Europe Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 105: Rest of Western Europe Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 106: Acyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 107: Acyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 108: Valacyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 109: Valacyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 110: Famciclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 111: Famciclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 112: Oral Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 113: Oral Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 114: Topical Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 115: Topical Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 116: Injectable Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 117: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 118: HSV-1 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 119: HSV-1 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 120: HSV-2 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 121: HSV-2 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 122: Hospital Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 123: Hospital Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 124: Retail Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 125: Retail Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 126: Online Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 127: Online Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 128: Drug Stores Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 129: Drug Stores Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 130: Western Europe Genital Herpes Treatment Market Attractiveness Analysis By Drug Class, 2017–2027 Figure 131: Western Europe Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 Figure 132: Western Europe Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 Figure 133: Western Europe Genital Herpes Treatment Market Attractiveness Analysis By Distributor Channel, 2017–2027 Figure 134: Western Europe Genital Herpes Treatment Market Attractiveness Analysis By Country, 2017–2027 Figure 135: Genital Herpes Treatment Market Split By Drug Type (2017) Figure 136: Genital Herpes Treatment Market Split By Route of Administration(2017) Figure 137: Genital Herpes Treatment Market Split By Indication(2017) Figure 138: Genital Herpes Treatment Market Split By Distribution Channel (2017) Figure 139: Genital Herpes Treatment Market Split By Country (2017) Figure 140: Eastern Europe Genital Herpes Treatment Market Size Analysis, 2012–2016 Figure 141: Eastern Europe Genital Herpes Treatment Market Forecast & Y-o-Y growth, 2017–2027 Figure 142: Russia Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 143: Russia Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 144: Poland Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 145: Poland Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 146: Rest of Eastern Europe Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 147: Rest of Eastern Europe Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 148: Acyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 149:Acyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 150: Valacyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 151: Valacyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 152: Famciclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 153: Famciclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 154: Oral Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 155: Oral Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 156: Topical Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 157: Topical Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 158: Injectable Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 159: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 160: HSV-1 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 161: HSV-1 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 162: HSV-2 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 163: HSV-2 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 164: Hospital Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 165: Hospital Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 166: Retail Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 167: Retail Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 168: Online Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 169: Online Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 170: Drug Stores Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 171: Drug Stores Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 172: Eastern Europe Genital Herpes Treatment Market Attractiveness Analysis By Drug Class, 2017–2027 Figure 173: Eastern Europe Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 Figure 174: Eastern Europe Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 Figure 175: Eastern Europe Genital Herpes Treatment Market Attractiveness Analysis By Distributor Channel, 2017–2027 Figure 176: Eastern Europe Genital Herpes Treatment Market Attractiveness Analysis By Country, 2017–2027 Figure 177: Genital Herpes Treatment Market Split By Drug Type (2017) Figure 178: Genital Herpes Treatment Market Split By Route of Administration(2017) Figure 179: Genital Herpes Treatment Market Split By Indication(2017) Figure 180: Genital Herpes Treatment Market Split By Distribution Channel (2017) Figure 181: Genital Herpes Treatment Market Split By Country (2017) Figure 182: APEJ Genital Herpes Treatment Market Size Analysis, 2012–2016 Figure 183: APEJ Genital Herpes Treatment Market Forecast & Y-o-Y growth, 2017–2027 Figure 184: China Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 185: China Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 186: India Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 187: India Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 188: Australia & New Zealand Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 189: Australia & New Zealand Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 190: ASEAN Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 191: ASEAN Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 192: Rest of APEJ Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 193: Rest of APEJ Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 194: Acyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 195: Acyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 196: Valacyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 197: Valacyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 198: Famciclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 199: Famciclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 200: Oral Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 201: Oral Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 202: Topical Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 203: Topical Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 204: Injectable Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 205: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 206: HSV-1 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 207: HSV-1 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 208: HSV-2 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 209: HSV-2 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 210: Hospital Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 211: Hospital Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 212: Retail Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 213: Retail Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 214: Online Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 215: Online Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 216: Drug Stores Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 217: Drug Stores Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 218: APEJ Genital Herpes Treatment Market Attractiveness Analysis By Drug Class, 2017–2027 Figure 219: APEJ Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 Figure 220: APEJ Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 Figure 221: APEJ Genital Herpes Treatment Market Attractiveness Analysis By Distributor Channel, 2017–2027 Figure 222: APEJ Genital Herpes Treatment Market Attractiveness Analysis By Country, 2017–2027 Figure 223: Genital Herpes Treatment Market Split By Drug Type (2017) Figure 224: Genital Herpes Treatment Market Split By Route of Administration(2017) Figure 225: Genital Herpes Treatment Market Split By Indication(2017) Figure 226: Genital Herpes Treatment Market Split By Country (2017) Figure 227:Japan Genital Herpes Treatment Market Size Analysis, 2012–2016 Figure 228: Japan Genital Herpes Treatment Market Forecast & Y-o-Y growth, 2017–2027 Figure 229: Acyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 230: Acyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 231: Valacyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 232: Valacyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 233: Famciclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 234: Famciclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 235: Oral Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 236: Oral Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 237: Topical Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 238: Topical Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 239: Injectable Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 240: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 241: HSV-1 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 242: HSV-1 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 243: HSV-2 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 244: HSV-2 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 245: Hospital Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 246: Hospital Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 247: Retail Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 248: Retail Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 249: Online Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 250: Online Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 251: Drug Stores Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 252: Drug Stores Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 253: Japan Genital Herpes Treatment Market Attractiveness Analysis By Drug Class, 2017–2027 Figure 254: Japan Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 Figure 255: Japan Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 Figure 256: Japan Genital Herpes Treatment Market Attractiveness Analysis By Distributor Channel, 2017–2027 Figure 257: Genital Herpes Treatment Market Split By Drug Type (2017) Figure 258: Genital Herpes Treatment Market Split By Route of Administration(2017) Figure 259: Genital Herpes Treatment Market Split By Indication(2017) Figure 260: Genital Herpes Treatment Market Split By Distribution Channel (2017) Figure 261: Genital Herpes Treatment Market Split By Country (2017) Figure 262: MEA Genital Herpes Treatment Market Size Analysis, 2012–2016 Figure 263: MEA Genital Herpes Treatment Market Forecast & Y-o-Y growth, 2017–2027 Figure 264: GCC Countries Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 265: GCC Countries Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 266: South Africa Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 267: South Africa Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 268: North Africa Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 269: North Africa Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 270: Rest of MEA Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 271: Rest of MEA Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 272: Acyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 273: Acyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 274: Valacyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 275: Valacyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 276: Famciclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 277: Famciclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 278: Oral Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 279: Oral Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 280: Topical Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 281: Topical Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 282: Injectable Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 283: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 284: HSV-1 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 285: HSV-1 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 286: HSV-2 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 287: HSV-2 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 288: Hospital Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 289: Hospital Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 290: Retail Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 291: Retail Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 292: Online Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 293: Online Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 294: Drug Stores Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016 Figure 295: Drug Stores Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027 Figure 296: MEA Genital Herpes Treatment Market Attractiveness Analysis By Drug Class, 2017–2027 Figure 297: MEA Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 Figure 298: MEA Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 Figure 299: MEA Genital Herpes Treatment Market Attractiveness Analysis By Distributor Channel, 2017–2027 Figure 300: MEA Genital Herpes Treatment Market Attractiveness Analysis By Country, 2017–2027 Figure 301: Global Genital Herpes Treatment Market Attractiveness Analysis By Region, 2017–2027 Figure 302: Global Genital Herpes Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 Figure 303: Global Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 Figure 304: Global Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 Figure 305: Global Genital Herpes Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 Figure 306: Global Genital Herpes Treatment Market Value Analysis and Forecast, 2016–2027 (US$ Mn) Figure 307: Global Genital Herpes Treatment Market Absolute $ Opportunity (US$ Mn), 2016–2027
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
